• A breath of unique innovation

    Pioneering inhalation products and extensive know-how in drug formulation

    Get to know us!

  • A formulation to match the device

    The right chemistry in the right inhaler takes you to the market faster

    Take me there!

  • Capitalize on a pool of knowledge

    Get from bench to bedside – faster and at lower risk

    Discover how

  • For those who need it the most

    ICOone™ – inhale vaccine instead of injecting. Safe method that eliminates all cold-chain storage.

    Learn how
  • A breath of unique innovation »
  • A formulation to match the device »
  • Capitalize on a pool of knowledge »
  • For those who need it the most »
Get in touch!

News

  • Directed share issue of 60 million SEK to finance Iconovo’s new inhalation platform

    2019-12-02
    A few weeks ago, Lund-based Iconovo gave a sign of their growing confidence when they announced the biggest investment i... Read more

  • Iconovo AB carries out a directed share issue and raises SEK 60 million before issue costs

    2019-12-02
    The Board of Directors of Iconovo AB ("Iconovo" or the “Company") has utilised the authorisation received at the AGM o... Read more

  • PRESS RELEASE, 19 November 2019

    2019-11-19
    Granted ICOres patent in Japan The Japan Patent Office has granted a patent regarding Iconovo’s dry powder inhaler, I... Read more

  • Iconovo met innovation companies at BIO-Europe

    2019-11-19
    At last week’s BIO-Europe conference, BioStock caught Iconovo’s Roger Lassing, VP of Business Development, between a... Read more

  • Iconovo’s new collaboration aims to optimise current inhalation products

    2019-11-14
    British CrystecPharma begins a collaboration with the Swedish inhaler developer Iconovo with the aim of formulating new ... Read more

  • PRESS RELEASE, 5 November 2019

    2019-11-05
    Iconovo and CrystecPharma to collaborate in development of innovative inhaler products Iconovo today announced that it ... Read more

  • MARKET ANALYS OF ICONOVO BY ERIK PENSER BANK (ONLY IN SWEDISH)

    2019-10-28
    Analys från Penser access: Iconovo - Tar klivet in i USA genom ny plattform. Läs mera här... Read more

  • PRESS RELEASE, 25 October 2019

    2019-10-25
    Iconovo AB (publ) makes a significant investment in the development of a new inhalation platform Iconovo AB (publ) anno... Read more

  • ICONOVO’S WEAPON IN THE FIGHT AGAINST ASTHMA

    2019-09-26
    Asthma has long been a significant global health issue and the problem only appears to grow. This summer a report from A... Read more

  • CLINICAL PROGRESS UPS THE VALUE OF ICONOVO’S FLAGSHIP PROJECT

    2019-08-28
    Lund based Iconovo did not sit still during the summer, instead the company released the biggest news of the year thus f... Read more
Older news

A unique platform of inhalation devices

Iconovo offers a full range of innovative, ready-to-use inhalation devices for dry powder inhalation (DPI). Our solution consists of a combination of inhaler and the exactly right formulation to match the device and the drug to be delivered. Each solution is based on our proprietary platform but will be customized and adapted to your unique requirements. We can also provide performance testing, full documentation and a complete supply chain. Our long and unique experience and capability in the development of inhalation devices and formulations enable you to get your product to the market in a fast and efficient way.
Find the right solution